Summit Trail Advisors’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.84M | Buy |
+4,741
| New | +$1.84M | 0.03% | 288 |
|
|
2024
Q4 | – | Sell |
-3,545
| Closed | -$1.84M | – | 508 |
|
|
2024
Q3 | $1.84M | Buy |
3,545
+469
| +15% | +$244K | 0.05% | 168 |
|
|
2024
Q2 | $1.67M | Buy |
3,076
+302
| +11% | +$164K | 0.04% | 163 |
|
|
2024
Q1 | $1.44M | Buy |
2,774
+810
| +41% | +$420K | 0.04% | 169 |
|
|
2023
Q4 | $926K | Sell |
1,964
-58
| -3% | -$27.4K | 0.03% | 191 |
|
|
2023
Q3 | $880K | Sell |
2,022
-460
| -19% | -$200K | 0.03% | 184 |
|
|
2023
Q2 | $1.1M | Buy |
2,482
+1,135
| +84% | +$504K | 0.04% | 156 |
|
|
2023
Q1 | $619K | Buy |
1,347
+472
| +54% | +$217K | 0.02% | 190 |
|
|
2022
Q4 | $449K | Buy |
875
+153
| +21% | +$78.5K | 0.02% | 200 |
|
|
2022
Q3 | $328K | Sell |
722
-24
| -3% | -$10.9K | 0.02% | 236 |
|
|
2022
Q2 | $360K | Buy |
+746
| New | +$360K | 0.02% | 235 |
|
|
2019
Q1 | – | Sell |
-2,270
| Closed | -$596K | – | 108 |
|
|
2018
Q4 | $596K | Sell |
2,270
-1,800
| -44% | -$473K | 0.21% | 52 |
|
|
2018
Q3 | $1.12M | Buy |
+4,070
| New | +$1.12M | 0.25% | 54 |
|
|
2018
Q2 | – | Sell |
-4,209
| Closed | -$246K | – | 534 |
|
|
2018
Q1 | $246K | Buy |
4,209
+3,075
| +271% | +$180K | 0.04% | 322 |
|
|
2017
Q4 | $280K | Buy |
+1,134
| New | +$280K | 0.04% | 336 |
|